Pharmacodynamics of the glucagon-like peptide-1 receptor agonist lixisenatide in Japanese and Caucasian patients with type 2 diabetes mellitus poorly controlled on sulphonylureas with/without metformin.

Seino, Y

Pharmacodynamics of the glucagon-like peptide-1 receptor agonist lixisenatide in Japanese and Caucasian patients with type 2 diabetes mellitus poorly controlled on sulphonylureas with/without metformin. [electronic resource] - Diabetes, obesity & metabolism Aug 2014 - 739-47 p. digital

Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1463-1326

10.1111/dom.12276 doi


Adult
Aged
Asian People
Cohort Studies
Diabetes Mellitus, Type 2--blood
Dose-Response Relationship, Drug
Double-Blind Method
Drug Monitoring
Drug Therapy, Combination--adverse effects
Female
Follow-Up Studies
Glucagon-Like Peptide-1 Receptor
Humans
Hypoglycemia--prevention & control
Hypoglycemic Agents--administration & dosage
Incretins--administration & dosage
Injections, Subcutaneous
Japan
Male
Metformin--therapeutic use
Middle Aged
Peptides--administration & dosage
Receptors, Glucagon--agonists
Sulfonylurea Compounds--therapeutic use
White People
Young Adult